TGFB1 and metabolic dysfunction-associated steatotic liver disease: At admission, TGF-β1 was significantly higher in patients with NAFLD (13,221 pg/mL, IQR 12,148–16,128 vs. 9447 pg/mL, IQR 6518–10,758, median difference 5599, 95%CI 2731 to 8468 pg/mL, p < 0.0001).